These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3393732)

  • 1. Fluorescence high performance liquid chromatographic analysis of free fatty acid levels changed during aggregation of rat platelets.
    Ikeda M; Matsumoto U
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):235-52. PubMed ID: 3393732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation in Finnish men and its relation to fatty acids in platelets, plasma and adipose tissue.
    Salo MK; Vartiainen E; Puska P; Nikkari T
    Thromb Haemost; 1985 Oct; 54(3):563-9. PubMed ID: 4089791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet aggregation and fatty acid oxidation in diabetic rats.
    Iida N; Iida R; Takeyama N; Tanaka T
    Biochem Mol Biol Int; 1993 May; 30(1):177-85. PubMed ID: 8358330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Free fatty acid composition of human semen in different clinical diagnoses].
    Hamfler HW; Nissen HP; Heinze I; Kreysel HW; Schirren C
    Andrologia; 1978; 10(6):498-50. PubMed ID: 736283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of dietary short and long chain saturated fatty acids on platelet functions, platelet phospholipids, and blood coagulation in rats.
    McGregor L; Morazain R; Renaud S
    Lab Invest; 1980 Nov; 43(5):438-42. PubMed ID: 7421125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concentration of free fatty acids in muscle following administration of corticotropin and hydrocortisone].
    Korkach VI; Iurchenko AA
    Biull Eksp Biol Med; 1978 Feb; 85(2):161-4. PubMed ID: 204375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of free fatty acids in blood, tagged with 4-(2-carbazoylpyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl )- 2,1,3-benzoxadiazole, by high-performance liquid chromatography with fluorescence detection.
    Toyo'oka T; Takahashi M; Suzuki A; Ishii Y
    Biomed Chromatogr; 1995; 9(4):162-70. PubMed ID: 8520204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of trapidil on fatty acid and prostaglandin metabolism in platelets.
    Tohjima T; Arisaka T; Honda N
    Clin Ther; 1994; 16(3):405-15. PubMed ID: 7923307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of long-chain free fatty acids by human platelets.
    Spector AA; Hoak JC; Warner ED; Fry GL
    J Clin Invest; 1970 Aug; 49(8):1489-96. PubMed ID: 5431660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of plasma free fatty acids by high-performance liquid chromatography with electrochemical detection.
    Kotani A; Fuse T; Kusu F
    Anal Biochem; 2000 Aug; 284(1):65-9. PubMed ID: 10933857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spectrum changes of free fatty acids in the plasma of rats with experimental nephrogenic hypertension].
    Michailov ML; Nitschkoff S; Hollstein E
    Dtsch Gesundheitsw; 1970 Sep; 25(39):1821-3. PubMed ID: 4320925
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid determination by high-performance liquid chromatography of free fatty acids released from rat platelets after derivatization with monodansylcadaverine.
    Lee YM; Nakamura H; Nakajima T
    J Chromatogr; 1990 Aug; 515():467-73. PubMed ID: 2283373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.